Jay Hoying

Chief Scientist
Advanced Solutions Life Sciences

James (Jay) Hoying, Ph.D. FAHA is Partner and Chief Scientist of Advanced Solutions Life Sciences (ASLS), a company pioneering solutions in vascularized tissue fabrication and biomanufacturing. Prior to joining ASLS, Dr. Hoying was the Chief of the Division of Cardiovascular Therapeutics at the Cardiovascular Innovation Institute (CII) and Professor in the Department Physiology at the University of Louisville. He has over 25 years of experience in basic and applied biological sciences research with a focus in tissue biology, tissue vascularization, and cell therapeutics. He received his Bachelor and Master’s degrees in Biology and Molecular Biology from Case Western Reserve University and his PhD in Cardiovascular Physiology, with an emphasis on the microcirculation, from the University of Arizona. Following this, Dr. Hoying served as a New Investigator in the National Institutes of Health Program of Excellence in Molecular Biology of the Heart and Lung (POEMB) in the Department of Molecular Genetics at the University of Cincinnati. He currently serves on the Editorial staff of two national scientific journals and reviews for several other national and international journals. Dr. Hoying reviews individual and program grant proposals for the National Institutes of Health, the Veterans Affairs, the American Heart Association, and international funding agencies. In addition to his numerous published works, Dr. Hoying holds patents related to vascularizing tissues and related cell-based therapies; technologies that have been translated to companies. Dr. Hoying was one of the first to publish in the area of vascularized tissue model fabrication. He is a Fellow of the American Heart Association.